CBCarlos BritesMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2019Treatment Options for HIV-TB Co-Infection - Carlos Brites, MD, PhDView Slideset
SlidesetHIVSalvador HIV Clinical Forum 2019Time to Change the Paradigm: Two vs. Three Drugs - Estevão Nunes, MDView Slideset
JPJorge PintoMD, DScSlidesetHIVSalvador HIV Clinical Forum 2019INSTIs Use in Pediatrics - Jorge Pinto, MD, DScView Slideset
SlidesetHIVSalvador HIV Clinical Forum 2019INSTIs Use in Women at Child-Bearing Age: NTD Risks - Isabella Nóbrega, MDView Slideset
MSMauro SchechterMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2019Role of INSTIs in HIV Prevention - Mauro Schechter, MD, PhDView Slideset
SlidesetHIVSalvador HIV Clinical Forum 2019Switching to INSTI-Based Treatment in Viral Suppressed Patients - Ian Frank, MDView Slideset
RDRicardo DiazMDSlidesetHIVSalvador HIV Clinical Forum 2019Experience with Dolutegravir in First-Line in Brazil - Ricardo Diaz, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2019Resistance to INSTIs and How Resistance Impacts Treatment Choices - Charles Boucher, MD, PhDView Slideset
SlidesetHIVSalvador HIV Clinical Forum 2019Toxicity Considerations When Choosing INSTIs - Ian Frank, MDView Slideset
DBDavid BackPhDSlidesetHIVSalvador HIV Clinical Forum 2019Pharmacology Considerations When Choosing INSTIs - David Back, PhDView Slideset
SlidesetHIVInternational Workshop on HIV and Transgender People 2020Surgeries and Body Modification Services - Rodrigo ItocazoView Slideset
